Sort by

Send to

Choose Destination

Links from PubMed

Items: 19


Targeting SLUG sensitizes leukemia cells to ADR-induced apoptosis.

Wei CR, Liu J, Yu XJ.

Int J Clin Exp Med. 2015 Dec 15;8(12):22139-48.


Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.

Hossain MJ, Xie L.

Cancer Epidemiol. 2015 Dec;39(6):892-900. doi: 10.1016/j.canep.2015.10.020.


Development of Bioinformatics Pipeline for Analyzing Clinical Pediatric NGS Data.

Crowgey EL, Kolb A, Wu CH.

AMIA Jt Summits Transl Sci Proc. 2015 Mar 23;2015:207-11.


Inhibition of ERK5 enhances cytarabine-induced apoptosis in acute myeloid leukemia cells.

Xu Y, Cao C, Gong X, Rong L.

Int J Clin Exp Med. 2015 Apr 15;8(4):6446-55.


Targeting cell cycle regulators in hematologic malignancies.

Aleem E, Arceci RJ.

Front Cell Dev Biol. 2015 Apr 9;3:16. doi: 10.3389/fcell.2015.00016. Review.


Molecular therapeutic approaches for pediatric acute myeloid leukemia.

Tasian SK, Pollard JA, Aplenc R.

Front Oncol. 2014 Mar 18;4:55. doi: 10.3389/fonc.2014.00055. Review.


Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.

Xie C, Drenberg C, Edwards H, Caldwell JT, Chen W, Inaba H, Xu X, Buck SA, Taub JW, Baker SD, Ge Y.

PLoS One. 2013 Nov 11;8(11):e79106. doi: 10.1371/journal.pone.0079106.


Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia.

Burke MJ, Wagner JE, Cao Q, Ustun C, Verneris MR.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1021-5. doi: 10.1016/j.bbmt.2013.04.001.


Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells.

Chen Y, Xu Y, Zhu Y, Li X.

Cancer Cell Int. 2013 Mar 12;13(1):24. doi: 10.1186/1475-2867-13-24.


A polymorphism in the 3'-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemia.

Cheng CK, Kwan TK, Cheung CY, Ng K, Liang P, Cheng SH, Chan NP, Ip RK, Wong RS, Lee V, Li CK, Yip SF, Ng MH.

Haematologica. 2013 Jun;98(6):913-7. doi: 10.3324/haematol.2012.073015.


Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.

Xie C, Edwards H, Lograsso SB, Buck SA, Matherly LH, Taub JW, Ge Y.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1245-51. doi: 10.1002/pbc.24152.


Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric acute myeloid leukemia cells.

Xu X, Xie C, Edwards H, Zhou H, Buck SA, Ge Y.

PLoS One. 2011 Feb 16;6(2):e17138. doi: 10.1371/journal.pone.0017138.


Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia.

Xie C, Edwards H, Xu X, Zhou H, Buck SA, Stout ML, Yu Q, Rubnitz JE, Matherly LH, Taub JW, Ge Y.

Clin Cancer Res. 2010 Nov 15;16(22):5499-510. doi: 10.1158/1078-0432.CCR-10-1707.


The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.

Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG.

Pediatr Blood Cancer. 2010 Sep;55(3):414-20. doi: 10.1002/pbc.22511.


High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.

Kang HJ, Lee JW, Kho SH, Kim MJ, Seo YJ, Kim H, Shin HY, Ahn HS.

J Korean Med Sci. 2010 Jun;25(6):841-5. doi: 10.3346/jkms.2010.25.6.841.


Novel targeted drug therapies for the treatment of childhood acute leukemia.

Brown P, Hunger SP, Smith FO, Carroll WL, Reaman GH.

Expert Rev Hematol. 2009 Apr 1;2(9):145.


Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH, Burke MJ, Blazar BR, Miller JS, McGlave PB, Weisdorf DJ, Wagner JE.

Blood. 2009 Nov 5;114(19):4293-9. doi: 10.1182/blood-2009-05-220525.


RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.

Edwards H, Xie C, LaFiura KM, Dombkowski AA, Buck SA, Boerner JL, Taub JW, Matherly LH, Ge Y.

Blood. 2009 Sep 24;114(13):2744-52. doi: 10.1182/blood-2008-09-179812.


Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.

Schiffman JD, Wang Y, McPherson LA, Welch K, Zhang N, Davis R, Lacayo NJ, Dahl GV, Faham M, Ford JM, Ji HP.

Cancer Genet Cytogenet. 2009 Aug;193(1):9-18. doi: 10.1016/j.cancergencyto.2009.03.005.

Items per page

Supplemental Content

Support Center